Robert A. Scott - 23 Oct 2026 Form 3/A - Amendment Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Reporting relationship: Director
Issuer ticker: ARQT
Reported as of: 23 Oct 2026
Net transaction value: $0
SEC form: 3/A - Amendment
Accepted by SEC: 04 Nov 2026, 18:38:37 UTC
Original report date: 28 Oct 2026
Prior SEC filing: 25 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Latha Vairavan, as Attorney-in-Fact for Robert A. Scott

Filing notes and source

Key filing fact

Robert A. Scott filed Form 3/A - Amendment for Arcutis Biotherapeutics, Inc. (ARQT) on 04 Nov 2026.

Key facts

This page summarizes Robert A. Scott's Form 3/A - Amendment filing for Arcutis Biotherapeutics, Inc. (ARQT).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Nov 2026, 18:38.

Change

Previous filing in this sequence was filed on 25 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001248520 Primary reporting owner

SCOTT ROBERT A

Relationship: Director
Address: C/O ARCUTIS BIOTHERAPEUTICS, INC., 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE
Signature: /s/ Latha Vairavan, as Attorney-in-Fact for Robert A. Scott
Signature date: 04 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 17,523
Date: 23 Oct 2026
Ownership: The Scott Family Trust
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares held by The Scott Family Trust dated January 31, 2020, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.